快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
周亚兵,罗若茵,赵莉,朱德增.酸味中药复方对实验性2型糖尿病大鼠胰岛素抵抗的影响[J].中国中西医结合杂志,2005,(5):441-444
酸味中药复方对实验性2型糖尿病大鼠胰岛素抵抗的影响
Effect of Sour TCM Compound Recipe on Insulin Resistance in Experimental Rats with Diabetes Mellitus Type 2
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  酸味中药  2型糖尿病  胰岛素抵抗  游离脂肪酸  肿瘤坏死因子α
英文关键词:sour tasted Chinese drug  diabetes mellitus type 2  insulin resistance  free fatty acids  tumor necrosis factor α
基金项目:国家中医药管理局中医药科学技术研究基金资助(No.02-03LP48)
作者单位
周亚兵 第二军医大学附属长海医院中医科 上海200433 
罗若茵 第二军医大学附属长海医院中医科 上海200433 
赵莉 第二军医大学附属长海医院中医科 上海200433 
朱德增 第二军医大学附属长海医院中医科 上海200433 
摘要点击次数: 1234
全文下载次数: 1780
中文摘要:
      目的根据中医学五行五味“酸克甘”理论,观察酸味中药复方对实验性2型糖尿病大鼠血糖及其胰岛素抵抗的影响。方法采用高热量饲料持续喂养8周联合腹腔注射小剂量链脲佐菌素的方法,建立2型糖尿病大鼠模型,用酸味中药复方按中药生药量15g·kg-1 ·d-1 给药,并与模型组、甘味复方组、苦味复方组、二甲双胍组作对照,分别在给药前和给药第4、8、12周后,测定空腹血糖(fastingbloodglucose ,FBG)、血清胰岛素、游离脂肪酸(freefattyacids,FFA)、肿瘤坏死因子α(tumornecrosisfactorα,TNF- α)、肝脏胰岛素受体结合容量和结合常数,计算胰岛素敏感性指数。结果酸味中药复方能显著降低实验性2型糖尿病大鼠FBG ,降低血清FFA和TNF -α水平,刺激胰岛素分泌,提高肝脏胰岛素受体结合容量和结合常数,改善胰岛素敏感性,与模型组比较差异有显著性(P <0 .0 5)。结论酸味中药复方能够改善2型糖尿病模型大鼠的糖代谢紊乱和胰岛素抵抗程度,较之甘味复方和苦味复方有一定的治疗优势,初步揭示酸克甘法治疗2型糖尿病理论具有一定的科学性和临床指导价值。
英文摘要:
      ObjectiveTo study the effect of sour TCM compound Recipe (SCCR) on insulin resistance in experimental rats with diabetes mellitus type 2 (DM2), under the guidance of TCM doctrine of "sour restrains sweet". MethodsModel rats of DM2 were established by 8 weeks’ feeding with high calorie forage combined with intraperitoneal injection of small dose of streptozotocin, and treated with SCCR (15 g/kg of crude drug/day). Levels of fasting blood glucose (FBG), serum insulin, free fatty acids (FFA), tumor necrosis factor α (TNF-α), combining capacity and constant of insulin receptor in liver were determined before treatment and 4,8 and 12 weeks after treatment, and the insulin sensitive index was calculated. The data were compared with those in the model group (untreated), sweet TCM compound recipe group and bitter TCM compound group (treated with sweet and bitter Chinese drugs respectively) and the control group (treated with dimethyldiguanide). ResultsSCCR could markedly reduce the FBG, serum FFA and TNF-α levels in rat model of DM2, stimulate the secretion of insulin, raise the combining capacity and constant of insulin receptor in liver and improve the insulin sensitivity, as compared with the effect of sweet or bitter Chinese compound recipe, the difference was significant (P<0.05). ConclusionSCCR could improve the glucose metabolic disorder and ameliorate the degree of insulin resistance in DM2 model rats, with the effect superior to those with sweet or bitter taste, which illustrates primarily that the therapeutic principle of "sour restrains sweet" of TCM is true of science in a certain degree and having its guiding significance in clinical practice.
关闭